EUVIMEDEUVIMED entdecken
Crossref

CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy

Bowen Lin, Jizheng Wang iD, Can Li, Shuiyun Wang iD, Meiting Shen, Lingjie Hu, Lei Chen iD, Fanhong Zhou, Yiqiao Liu, Jian Yang iD, Mo Zhang iD, Dong Wang und 5 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.075290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Bowen Lin und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Diseases and Department of Cardiology (B.L., C.L., M.S., L.H., L.C., J.Y., D.S., Y.-H.C.), School of Medicine,…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Fibroblasts, Receptors, Cytokine, Myocardium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypertrophic cardiomyopathy (HCM), the most common inherited cardiac disorder and a leading cause of sudden cardiac death in young adults, exhibits substantial genetic and clinical heterogeneity. Although sarcomere gene sequence variations account for a major proportion of HCM cases, nearly half of patients lack identifiable genetic defects, implying the involvement of undiscovered mechanisms that may converge on a common pathogenic pathway. However, a unified molecular basis underlying HCM pathogenesis remains undefined. METHODS: We conducted an integrated analysis of hypertrophied interventricular septum tissues from 269 patients with obstructive HCM undergoing surgical myectomy. Targeted sarcomere gene screening, bulk RNA sequencing, and weighted gene coexpression network analysis were used to identify candidate drivers of disease. Cross-species validation was performed using a Myh 6 R404Q/+ mouse model. Single-cell RNA sequencing delineated the cellular source of key factors, and biochemical assays and gain- and loss-of-function studies were used to assess their functional relevance. CRLF1 (cytokine receptor-like factor 1) emerged as a candidate mediator and was further evaluated in vitro and in vivo. RESULTS: CRLF1, predominantly secreted by activated cardiac fibroblasts, emerged as a key paracrine factor driving cardiomyocyte hypertrophy across patients with genetically heterogeneous HCM. CRLF1 levels were significantly elevated in hypertrophied myocardium and circulation. CRLF1 activated the LIFR (leukemia inhibitory factor receptor)–JAK1/2 (Janus kinase)–STAT3 (signal transducer and activator of transcription 3) signaling cascade to promote hypertrophy in both murine and human HCM models. Genetic ablation of Crlf1 in fibroblasts or pharmacological inhibition of its downstream pathway markedly attenuated disease phenotypes. CONCLUSIONS: Our findings uncover a common, nongenetic paracrine mechanism underlying HCM pathogenesis and establish CRLF1 as a promising universal therapeutic target for this heterogeneous disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicFibroblastsReceptors, CytokineMyocardiumHumansAnimalsMiceSTAT3 Transcription FactorFemaleMaleJanus Kinase 2Signal TransductionSeptal MyectomyDisease Models, AnimalAdultMiddle AgedMyocytes, CardiacParacrine Communication

Stichwörter der Autor:innen

cardiomyopathiescardiomyopathy, hypertrophicfibroblasts

Substanzen

STAT3 Transcription FactorReceptors, CytokineJanus Kinase 2STAT3 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Cardiovascular Diseases and Department of Cardiology (B.L., C.L., M.S., L.H., L.C., J.Y., D.S., Y.-H.C.), School of Medicine, Tongji University, Shanghai, China.
  • Shanghai Arrhythmia Research Center (B.L., C.L., M.S., L.H., L.C., J.Y., D.S., Y.-H.C.), School of Medicine, Tongji University, Shanghai, China.
  • State Key Laboratory of Cardiovascular Disease (J.W., M.Z., D.W., L.S.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cardiomyopathy Ward (J.W., M.Z., D.W., L.S.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiovascular Surgery (S.W.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jinzhou Medical University, Liaoning, China (F.Z., Y.L.).

ORCID-Profile: Jizheng Wang, Shuiyun Wang, Lei Chen, Jian Yang, Mo Zhang, Guoliang Xu, Bin Zhou, Lei Song, Dan Shi, Yi-Han Chen

Zitieren

APA

Lin, B., Wang, J., Li, C., Wang, S., Shen, M., Hu, L., Chen, L., Zhou, F., Liu, Y., Yang, J., Zhang, M., Wang, D., Xu, G., Zhou, B., Song, L., Shi, D., & Chen, Y. H. (2026). CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. Circulation. https://doi.org/10.1161/circulationaha.125.075290

Vancouver

Lin B, Wang J, Li C, Wang S, Shen M, Hu L, et al. CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. Circulation. 2026. doi:10.1161/circulationaha.125.075290

BibTeX
@article{Lin2026,
  author = {Lin, Bowen and Wang, Jizheng and Li, Can and Wang, Shuiyun and Shen, Meiting and Hu, Lingjie and Chen, Lei and Zhou, Fanhong and Liu, Yiqiao and Yang, Jian and Zhang, Mo and Wang, Dong and Xu, Guoliang and Zhou, Bin and Song, Lei and Shi, Dan and Chen, Yi-Han},
  title = {CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.075290}
}
Kostenlos starten →